Frequency of anticancer drug use at the end of life: a scoping review

PURPOSE: Anticancer drug use at the end of life places potential extra burdens on patients and the healthcare system. Previous articles show variability in methods and outcomes; thus, their results are not directly comparable. This scoping review describes the methods and extent of anticancer drug u...

Descripción completa

Detalles Bibliográficos
Autores principales: Szigethy, Endre, Dorantes, Rosario, Sugrañes, Miguel, Madera, Meisser, Sola, Ivan, Urrútia, Gerard, Bonfill, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247343/
https://www.ncbi.nlm.nih.gov/pubmed/37286888
http://dx.doi.org/10.1007/s12094-023-03234-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247343/
https://www.ncbi.nlm.nih.gov/pubmed/37286888
http://dx.doi.org/10.1007/s12094-023-03234-1

Ejemplares similares